Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused ...

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...

Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.

Merus N.V. (Nasdaq: MRUS) ("Merus"), an oncology company developing innovative, full-length multispecific antibodies and ...

Despite today’s sharp gains, IdeaForge Technology shares at its day’s high were still 21% lower from the 52-week high of Rs ...

Spin-Out from the Women Founders of InHealth Launches Seed Round to Scale Modular, Evidence-Based AI Coaching Platform WILMINGTON, DE / ACCESS Newswire / November 17, 2025 / CoachLinQ, the industry's ...

No near-term Reverse Stock Split required to meet Bid Price Rule. HOUSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Plus ...

As I write, four big dividend payers (dishing divvies between 5% and 6%) are trading at bargain-basement valuations.

Export Barbados (BIDC) and EarlyHealth Group (EHG), have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world-class pharmaceutical and life sciences cluster ...

The good news/boring dystopia portion of it is that it's usually just done for marketing purposes to sell you more products, ...

TONMYA is now available by prescription and available for pharmacy ordering nationwideTONMYA is the first FDA-approved treatment for fibromyalgia ...

Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS technology in reducing ...